Intellia Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intellia Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Intellia Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -52 %, a 28.4% decline year-over-year.
  • Intellia Therapeutics, Inc. annual Return On Equity for 2023 was -43.9 %, a 9.84% increase from 2022.
  • Intellia Therapeutics, Inc. annual Return On Equity for 2022 was -48.7 %, a 44.9% decline from 2021.
  • Intellia Therapeutics, Inc. annual Return On Equity for 2021 was -33.6 %, a 8.84% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -43.9 +4.79 +9.84% Jan 1, 2023 Dec 31, 2023
2022 -48.7 -15.1 -44.9% Jan 1, 2022 Dec 31, 2022
2021 -33.6 +3.26 +8.84% Jan 1, 2021 Dec 31, 2021
2020 -36.9 +138 +78.9% Jan 1, 2020 Dec 31, 2020
2019 -175 -144 -471% Jan 1, 2019 Dec 31, 2019
2018 -30.6 +0.68 +2.17% Jan 1, 2018 Dec 31, 2018
2017 -31.3 -11 -54.3% Jan 1, 2017 Dec 31, 2017
2016 -20.3 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.